The CF&B European Midcap Event connects listed European growth companies with institutional investors through a programme of one-on-one meetings and presentations. It provides an important forum for companies to discuss their strategy, progress, and long-term value creation with the investment community.

CHOSA will be represented by Claus Frisenberg Pedersen, Chief Commercial Officer, who will be meeting with existing and prospective investors to discuss the company's commercial strategy, clinical progress, and future growth opportunities.

Interested in meeting Claus during the event? Contact us using the button below to arrange a meeting.